Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research Hospital in Turkey

Başlangıç: 2010
Yayıncı: Sağlık Araştırmaları Derneği

Objective: We analyzed the incidence of heparin-induced thrombocytopenia in a group of

Keywords:

Heparin thrombocytopenia, hospital setting, incidence,

1. Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. Thromb Haemost. 2005;94:132-5.
2. Theodore E, Warkentin MD. Heparin-Induced Thrombocytopenia. Hematol/Oncol Clin North Am. 2007;21:589–607.
3. Greinacher A. Heparin-Induced Thrombocytopenia. The New England Journal of Medicine. 2015:373:252–261.
4. Arepally G, Cines DB. Pathogenesis of heparin-induced thrombocytopenia and thrombosis. 2002;1:125–132.
5. Bakchoul T. An update on heparin-induced thrombocytopenia: diagnosis and management. Expert Opinion on Drug Safety. 2016;15:787–97.
6. Bakchoul T, Greinacher A. Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia. Ther Adv Hematol. 2012;3:237–51.
7. Solomon CG, Greinacher A. Heparin-Induced Thrombocytopenia. New Engl J Med. 2015;373:252–61.
8. Gruel Y, Régina S, Pouplard C. Usefulness of pretest clinical score (4Ts) combined with immunoassay for the diagnosis of heparin-induced thrombocytopenia. Current Opinion in Pulmonary Medicine. 2008;14:397–402.
9. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low- molecular-weight heparin thromboprophylaxis : a meta-analysis. Blood. 2016;106:2710–6.
10. Yim JM, Frazier JL. Ranitidine and thrombocytopenia. Journal of Pharmacy Technology. 1995;11:263–6.